Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Stoke Therapeutics (STOK) CMO sells 14,311 shares in planned trades
Stoke Therapeutics’ Chief Medical Officer, Barry Ticho, exercised stock options and subsequently sold 14,311 shares of common stock in pre-planned transactions between March 17-19, 2026. These sales, conducted under a Rule 10b5-1 trading plan and partly to cover tax withholdings, are described as routine liquidity events rather than new signals about the stock. Following these trades, Ticho directly holds 40,702 shares of the company’s common stock.